{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:04:52Z","timestamp":1762866292709,"version":"3.40.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1002\/jps.23765","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T22:50:27Z","timestamp":1383346227000},"page":"337-349","source":"Crossref","is-referenced-by-count":10,"title":["CYP1A1 and CYP1B1-Mediated Biotransformation of the Antitrypanosomal Methamidoxime Prodrug DB844 Forms Novel Metabolites Through Intramolecular Rearrangement"],"prefix":"10.1016","volume":"103","author":[{"given":"Wujian","family":"Ju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihyung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Ansede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad E.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene S.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Voyksner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Boykin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Tidwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Edwin","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"375","key":"10.1002\/jps.23765_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"9709","author":"Brun","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/jps.23765_bb0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: Pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1002\/jps.23765_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0035-9203(91)90032-T","article-title":"African trypanosomiasis and drug-induced encephalopathy: Risk factors and pathogenesis","volume":"85","author":"Pepin","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1002\/jps.23765_bb0025","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/jpet.108.149872","article-title":"Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: Effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein","volume":"329","author":"Sanderson","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1002\/jps.23765_bb0030","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/jm00219a023","article-title":"Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)thiophenes and -pyrroles","volume":"20","author":"Das","year":"1977","journal-title":"J Med Chem"},{"issue":"3","key":"10.1002\/jps.23765_bb0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0014-4894(81)90099-0","article-title":"Leishmania donovani, Plasmodium berghei, Trypanosoma rhodesiense: Antiprotozoal effects of some amidine types","volume":"52","author":"Steck","year":"1981","journal-title":"Exp Parasitol"},{"issue":"1","key":"10.1002\/jps.23765_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-4894(82)90099-6","article-title":"Trypanosoma rhodesiense: Evaluation of the antitrypanosomal action of 2,5-bis4-guanylphenyl)furan dihydrochloride","volume":"53","author":"Steck","year":"1982","journal-title":"Exp Parasitol"},{"issue":"11","key":"10.1002\/jps.23765_bb0045","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1023\/A:1020957430400","article-title":"Enhanced permeability of the antimicrobial agent 2,5-bis4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug","volume":"19","author":"Zhou","year":"2002","journal-title":"Pharm Res"},{"issue":"4","key":"10.1002\/jps.23765_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jms.591","article-title":"Metabolites of an orally active antimicrobial prodrug, 2,5-bis4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography\/tandem mass spectrometry","volume":"39","author":"Zhou","year":"2004","journal-title":"J Mass Spectrom"},{"issue":"12","key":"10.1002\/jps.23765_bb0055","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1124\/dmd.106.010587","article-title":"CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis4-amidinophenyl)furan-bis-O-methylamidoxime]","volume":"34","author":"Wang","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1002\/jps.23765_bb0060","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1124\/dmd.105.005017","article-title":"Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase","volume":"33","author":"Saulter","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1002\/jps.23765_bb0065","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1124\/dmd.107.016428","article-title":"Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine","volume":"35","author":"Wang","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1002\/jps.23765_bb0070","first-page":"876","article-title":"Diamidines for human African trypanosomiasis","volume":"11","author":"Paine","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"issue":"22","key":"10.1002\/jps.23765_bb0075","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/jm0302602","article-title":"Synthesis and antiprotozoal activity of aza-analogues of furamidine","volume":"46","author":"Ismail","year":"2003","journal-title":"J Med Chem"},{"issue":"10","key":"10.1002\/jps.23765_bb0080","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/AAC.00225-09","article-title":"New treatment option for second-stage African sleeping sickness: In vitro and in vivo efficacy of aza analogs of DB289","volume":"53","author":"Wenzler","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1002\/jps.23765_bb0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/00498250500087671","article-title":"In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis","volume":"35","author":"Ansede","year":"2005","journal-title":"Xenobiotica"},{"issue":"7","key":"10.1002\/jps.23765_bb0090","doi-asserted-by":"crossref","first-page":"e1734","DOI":"10.1371\/journal.pntd.0001734","article-title":"Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis","volume":"6","author":"Thuita","year":"2012","journal-title":"PLoS Neglect Trop Dis"},{"issue":"3","key":"10.1002\/jps.23765_bb0095","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/AAC.00831-08","article-title":"Efficacy of the novel diamidine compound 2,5-Bis4-amidinophenyl)- furan-bis-O-methlylamidoxime Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration","volume":"53","author":"Mdachi","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1002\/jps.23765_bb0100","doi-asserted-by":"crossref","first-page":"e2230","DOI":"10.1371\/journal.pntd.0002230","article-title":"Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis","volume":"7","author":"Thuita","year":"2013","journal-title":"PLoS Neglect Trop Dis"},{"issue":"4","key":"10.1002\/jps.23765_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jlcr.817","article-title":"Synthesis of deuterium-labelled 6-[5-4-amidinophenyl)furan-2-yl]nicotinamidine and N-alkoxy-6-{5-[4-N-alkoxyamidino)phenyl]-furan-2-yl}-nicotinamidines","volume":"47","author":"Ismail","year":"2004","journal-title":"J Label Compd Rad"},{"issue":"3","key":"10.1002\/jps.23765_bb0110","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1124\/jpet.104.072389","article-title":"NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans","volume":"311","author":"Kurian","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1002\/jps.23765_bb0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0090-9556(24)14911-2","article-title":"Cytochrome P-450 1A1 expression in human small bowel: Interindividual variation and inhibition by ketoconazole","volume":"27","author":"Paine","year":"1999","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1002\/jps.23765_bb0120","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0026-895X(25)09132-1","article-title":"Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens","volume":"41","author":"Shimada","year":"1992","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1002\/jps.23765_bb0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1248\/bpb.32.513","article-title":"Involvement of the CYP1A subfamily in stereoselective metabolism of carvedilol in beta-naphthoflavone-treated Caco-2 cells","volume":"32","author":"Ishida","year":"2009","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"10.1002\/jps.23765_bb0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/00498250903003135","article-title":"Cynomolgus monkey CYPs: A comparison with human CYPs","volume":"39","author":"Iwasaki","year":"2009","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1002\/jps.23765_bb0135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2133\/dmpk.25.290","article-title":"Regional distribution of cytochrome p450 mRNA expression in the liver and small intestine of cynomolgus monkeys","volume":"25","author":"Nakanishi","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7","key":"10.1002\/jps.23765_bb0140","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1172\/JCI31647","article-title":"Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut","volume":"117","author":"Ito","year":"2007","journal-title":"J Clin Invest"},{"issue":"196","key":"10.1002\/jps.23765_bb0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-3-642-00663-0_13","article-title":"Drug-induced liver injury in humans: The case of ximelagatran","author":"Keisu","year":"2010","journal-title":"Handb Exp Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915307528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915307528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T19:25:13Z","timestamp":1746041113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915307528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022354915307528"],"URL":"https:\/\/doi.org\/10.1002\/jps.23765","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}